Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer

The occurrence of multidrug-resistant Candida auris isolates and the increased mortality associated with invasive infections or outbreaks due to this Candida species have been reported in many healthcare settings. Therefore, accurate and rapid identification at the species level of clinical C. auris...

Full description

Bibliographic Details
Main Authors: Elena De Carolis, Federica Marchionni, Marilisa La Rosa, Jacques F. Meis, Anuradha Chowdhary, Brunella Posteraro, Maurizio Sanguinetti
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.645049/full
id doaj-51ceaa8270a94550931d487369dcf340
record_format Article
spelling doaj-51ceaa8270a94550931d487369dcf3402021-03-16T06:08:01ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882021-03-011110.3389/fcimb.2021.645049645049Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the AnswerElena De Carolis0Federica Marchionni1Marilisa La Rosa2Jacques F. Meis3Jacques F. Meis4Anuradha Chowdhary5Brunella Posteraro6Maurizio Sanguinetti7Maurizio Sanguinetti8Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyDipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyDipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyDepartment of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, NetherlandsCentre of Expertise in Mycology, Radboudumc/Canisius Wilhelmina Hospital, Nijmegen, NetherlandsVallabhbhai Patel Chest Institute, Department of Medical Mycology, University of Delhi, Delhi, IndiaDipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, ItalyDipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyDipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, ItalyThe occurrence of multidrug-resistant Candida auris isolates and the increased mortality associated with invasive infections or outbreaks due to this Candida species have been reported in many healthcare settings. Therefore, accurate and rapid identification at the species level of clinical C. auris isolates as well as their timely differentiation as susceptible or resistant to antifungal drugs is mandatory. Aims of the present study were to implement the MALDI-TOF mass spectrometry (MS) Bruker Daltonics Biotyper® database with C. auris spectrum profiles and to develop a fast and reproducible MS assay for detecting anidulafungin (AFG) resistance in C. auris isolates. After creation of main C. auris spectra, a score-oriented dendrogram was generated from hierarchical cluster analysis, including spectra of isolates from C. auris and other Candida (C. glabrata, C. guilliermondii, C. haemulonii, C. lusitaniae, and C. parapsilosis) or non-Candida (Rhodotorula glutinis) species. Cluster analysis allowed to group and classify the isolates according to their species designation. Then, a three-hour incubation antifungal susceptibility testing (AFST) assay was developed. Spectra obtained at null, intermediate, or maximum AFG concentrations were used to create composite correlation index matrices for eighteen C. auris isolates included in the study. All six resistant C. auris isolates were detected as resistant whereas 11 of 12 susceptible C. auris isolates were detected as susceptible by the MS-AFST assay. In conclusion, our MS-based assay offers the possibility of rapidly diagnosing and appropriately treating patients with C. auris infection.https://www.frontiersin.org/articles/10.3389/fcimb.2021.645049/fullCandida auris3-hour MS-AFSTmultidrug resistanceanidulafunginnew emerging pathogenrapid identification and susceptibility testing
collection DOAJ
language English
format Article
sources DOAJ
author Elena De Carolis
Federica Marchionni
Marilisa La Rosa
Jacques F. Meis
Jacques F. Meis
Anuradha Chowdhary
Brunella Posteraro
Maurizio Sanguinetti
Maurizio Sanguinetti
spellingShingle Elena De Carolis
Federica Marchionni
Marilisa La Rosa
Jacques F. Meis
Jacques F. Meis
Anuradha Chowdhary
Brunella Posteraro
Maurizio Sanguinetti
Maurizio Sanguinetti
Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer
Frontiers in Cellular and Infection Microbiology
Candida auris
3-hour MS-AFST
multidrug resistance
anidulafungin
new emerging pathogen
rapid identification and susceptibility testing
author_facet Elena De Carolis
Federica Marchionni
Marilisa La Rosa
Jacques F. Meis
Jacques F. Meis
Anuradha Chowdhary
Brunella Posteraro
Maurizio Sanguinetti
Maurizio Sanguinetti
author_sort Elena De Carolis
title Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer
title_short Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer
title_full Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer
title_fullStr Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer
title_full_unstemmed Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer
title_sort are we ready for nosocomial candida auris infections? rapid identification and antifungal resistance detection using maldi-tof mass spectrometry may be the answer
publisher Frontiers Media S.A.
series Frontiers in Cellular and Infection Microbiology
issn 2235-2988
publishDate 2021-03-01
description The occurrence of multidrug-resistant Candida auris isolates and the increased mortality associated with invasive infections or outbreaks due to this Candida species have been reported in many healthcare settings. Therefore, accurate and rapid identification at the species level of clinical C. auris isolates as well as their timely differentiation as susceptible or resistant to antifungal drugs is mandatory. Aims of the present study were to implement the MALDI-TOF mass spectrometry (MS) Bruker Daltonics Biotyper® database with C. auris spectrum profiles and to develop a fast and reproducible MS assay for detecting anidulafungin (AFG) resistance in C. auris isolates. After creation of main C. auris spectra, a score-oriented dendrogram was generated from hierarchical cluster analysis, including spectra of isolates from C. auris and other Candida (C. glabrata, C. guilliermondii, C. haemulonii, C. lusitaniae, and C. parapsilosis) or non-Candida (Rhodotorula glutinis) species. Cluster analysis allowed to group and classify the isolates according to their species designation. Then, a three-hour incubation antifungal susceptibility testing (AFST) assay was developed. Spectra obtained at null, intermediate, or maximum AFG concentrations were used to create composite correlation index matrices for eighteen C. auris isolates included in the study. All six resistant C. auris isolates were detected as resistant whereas 11 of 12 susceptible C. auris isolates were detected as susceptible by the MS-AFST assay. In conclusion, our MS-based assay offers the possibility of rapidly diagnosing and appropriately treating patients with C. auris infection.
topic Candida auris
3-hour MS-AFST
multidrug resistance
anidulafungin
new emerging pathogen
rapid identification and susceptibility testing
url https://www.frontiersin.org/articles/10.3389/fcimb.2021.645049/full
work_keys_str_mv AT elenadecarolis arewereadyfornosocomialcandidaaurisinfectionsrapididentificationandantifungalresistancedetectionusingmalditofmassspectrometrymaybetheanswer
AT federicamarchionni arewereadyfornosocomialcandidaaurisinfectionsrapididentificationandantifungalresistancedetectionusingmalditofmassspectrometrymaybetheanswer
AT marilisalarosa arewereadyfornosocomialcandidaaurisinfectionsrapididentificationandantifungalresistancedetectionusingmalditofmassspectrometrymaybetheanswer
AT jacquesfmeis arewereadyfornosocomialcandidaaurisinfectionsrapididentificationandantifungalresistancedetectionusingmalditofmassspectrometrymaybetheanswer
AT jacquesfmeis arewereadyfornosocomialcandidaaurisinfectionsrapididentificationandantifungalresistancedetectionusingmalditofmassspectrometrymaybetheanswer
AT anuradhachowdhary arewereadyfornosocomialcandidaaurisinfectionsrapididentificationandantifungalresistancedetectionusingmalditofmassspectrometrymaybetheanswer
AT brunellaposteraro arewereadyfornosocomialcandidaaurisinfectionsrapididentificationandantifungalresistancedetectionusingmalditofmassspectrometrymaybetheanswer
AT mauriziosanguinetti arewereadyfornosocomialcandidaaurisinfectionsrapididentificationandantifungalresistancedetectionusingmalditofmassspectrometrymaybetheanswer
AT mauriziosanguinetti arewereadyfornosocomialcandidaaurisinfectionsrapididentificationandantifungalresistancedetectionusingmalditofmassspectrometrymaybetheanswer
_version_ 1724219983401058304